Benyamin Mashhadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Benyamin Mashhadi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Afshan Shirkavand
Department of Photodynamic, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran
1 shared publication - Armin Nazemi Zadeh
Department of Photodynamic, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran
1 shared publication - Fatemeh Haghdoost
Department of Regenerative Medicine in Wound Healing, Medical Laser Research Center, Yara Institute Academic Center for Education, Culture and Research (ACECR), Tehran, Iran
1 shared publication - Fedora Khatibi Shahidi
Department of Photodynamic, Medical Laser Research Center, Yara Institute, ACECR, Tehran, Iran
1 shared publication - Fereshteh Sarafrazi
Integrative Oncology Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
1 shared publication - Mahdi Hesaraki
Department of Animal Sciences and Marine Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in Materials Today Advances
- Vol. 32
Sonodynamic therapy for chronic wound healing: Cavitation-mediated ROS chemistry, hypoxia tolerance, and ultrasound-responsive platforms
- 15 October 2026
- Published by Elsevier in Materials Today Advances
- Vol. 32
Open AccessSonodynamic therapy for chronic wound healing: Cavitation-mediated ROS chemistry, hypoxia tolerance, and ultrasound-responsive platforms
- Open Access
- 30 July 2026
- Published by Maad Rayan Publishing Company in Biomedicine Advances
- Vol. 3 (3) , 92-104
Harnessing Regenerative Medicine to Improve Wound Healing Outcomes: Cellular Therapies, Biomaterials, and Nanomedicine
Regenerative medicine examines how to use stem cells, growth factors, cellular dressings, skin substitutes, biopolymers, hydrogels, exosome-based systems, and nanoparticle-enabled delivery platforms to improve Wound Healing. It is increasingly shaping the therapeutic and conceptual approach to wound care by shifting the goal of treatment from simple wound closure to the restoration of functional tissue. This review discusses the biological rationale of wound healing. The normal process of wound healing includes several coordinated and overlapping phases of hemostasis, inflammation, proliferation, and remodeling. This sequence often is disrupted in burns, diabetic ulcers, infected wounds, and extensive traumatic injuries, which leads to chronic inflammation, delayed vascularization, defective extracellular matrix deposition, or poor epithelial regeneration. Regenerative strategies, by providing instructive cells, paracrine signals, structural scaffolds, or controlled local delivery of bioactive molecules, try to correct these failures. Regenerative medicine has seen significant advances with the development of living skin substitutes, growth factor-loaded matrices, dynamic hydrogels, electrospun nanofibers, bioprintable bioinks, and smart wound dressings. However, the variability of biomaterial composition, poor regeneration of vascular and appendages, manufacturing complexity, cost, safety concerns, and the need for standardized potency assays still limit clinical translation. A more integrated approach that combines biological signaling, scaffold design, antimicrobial control, and patient-specific wound assessment may help bridge the gap between promising experimental systems and clinically reliable regenerative wound therapies.
- 30 July 2026
- Published by Maad Rayan Publishing Company in Biomedicine Advances
- Vol. 3 (3) , 92-104
Open AccessHarnessing Regenerative Medicine to Improve Wound Healing Outcomes: Cellular Therapies, Biomaterials, and Nanomedicine
Regenerative medicine examines how to use stem cells, growth factors, cellular dressings, skin substitutes, biopolymers, hydrogels, exosome-based systems, and nanoparticle-enabled delivery platforms to improve Wound Healing. It is increasingly shaping the therapeutic and conceptual approach to wound care by shifting the goal of treatment from simple wound closure to the restoration of functional tissue. This review discusses the biological rationale of wound healing. The normal process of wound healing includes several coordinated and overlapping phases of hemostasis, inflammation, proliferation, and remodeling. This sequence often is disrupted in burns, diabetic ulcers, infected wounds, and extensive traumatic injuries, which leads to chronic inflammation, delayed vascularization, defective extracellular matrix deposition, or poor epithelial regeneration. Regenerative strategies, by providing instructive cells, paracrine signals, structural scaffolds, or controlled local delivery of bioactive molecules, try to correct these failures. Regenerative medicine has seen significant advances with the development of living skin substitutes, growth factor-loaded matrices, dynamic hydrogels, electrospun nanofibers, bioprintable bioinks, and smart wound dressings. However, the variability of biomaterial composition, poor regeneration of vascular and appendages, manufacturing complexity, cost, safety concerns, and the need for standardized potency assays still limit clinical translation. A more integrated approach that combines biological signaling, scaffold design, antimicrobial control, and patient-specific wound assessment may help bridge the gap between promising experimental systems and clinically reliable regenerative wound therapies.